A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Pfizer
Eli Lilly and Company
Eli Lilly and Company
Mayo Clinic
Canadian Cancer Trials Group
American College of Radiology Imaging Network
University of Pisa
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center